CataX AI raises RMB 40 million seed round to bring AI agents into clinical drug development
This story is from 2026-11-16. It is preserved in the archive; the latest stories are on the live feed.
Shanghai-based CataX AI raised RMB 40 million in a seed round from Qiming Venture Partners, which incubated the startup and was the sole investor. The company plans to license or co-develop drug candidates using AI agents.
Read the full story at TechNode ↗
Timeline · 1 report
- 2026-11-16 06:36 · TechNode
CataX AI raises RMB 40 million to bring AI agents into clinical drug development